Cosmo Pharmaceuticals N.V.

Direct answer

Cosmo Pharmaceuticals N.V. is publicly traded on SIX under the ticker COPN.SW.

Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.

Can you invest in Cosmo Pharmaceuticals N.V.?

Yes. Cosmo Pharmaceuticals N.V. trades publicly on SIX as COPN.SW.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cosmo Pharmaceuticals N.V.

Detailed equity research is provided by MarketSnap.